nvgn, page-137

Novogen Mk 2 has been in existence since Dec 2012 and it has probably taken until Q2 2015 for the market to recognise the clear differences between the old and the new.

Success breeds success and each new result is helping to embed this expectation into the company profile. There will always be those who sieze quick profits but more and more appear to be looking at the bigger picture. In other words, the shorts or day traders are being replaced by longer term investors. This is evident from the on - balance volume which is consistently positive and also the development of higher highs and higher lows in the chart.

Notice that the naysayers are also thinning out - I put them on ignore anyway. They keep telling us that there is a long, long, long way to go.

And I think to myself well that's fine ... but so does the share price.